In a 69-year-old man with type 2 diabetes, hypertension, and substance‑use history who presents with acute right upper‑quadrant pain radiating to the back, fever, chills, shortness of breath, and bilateral pneumonia treated with ceftriaxone and doxycycline, and whose CT and RUQ ultrasound show a normal gallbladder, no gallstones, a common bile duct measuring 7.6 mm (minimally dilated for his age), normal bilirubin, normal alkaline phosphatase, normal transaminases, low lipase, and mild leukocytosis, should emergent endoscopic retrograde cholangiopancreatography (ERCP) be performed for suspected choledocholithiasis?

Should Emergent ERCP Be Performed in This Patient?

No, emergent ERCP should not be performed in this patient because his clinical presentation, laboratory values, and imaging findings do not support choledocholithiasis or acute cholangitis requiring urgent endoscopic intervention. 1

Why ERCP Is Not Indicated

Absence of Biliary Obstruction Criteria

• Normal bilirubin (total 0.7 mg/dL, direct 0.2 mg/dL) and normal alkaline phosphatase (49 U/L) effectively exclude clinically significant biliary obstruction. 1 Elevated bilirubin and alkaline phosphatase are the hallmark laboratory findings of choledocholithiasis requiring intervention.

• The common bile duct diameter of 7.6 mm is only minimally dilated for a 69-year-old patient (normal CBD increases approximately 1 mm per decade of life, making 7–8 mm acceptable in this age group). 1 This finding alone does not indicate obstruction.

• Normal transaminases (AST 17, ALT 11) argue strongly against acute biliary obstruction or cholangitis. 1 While alkaline phosphatase alone has poor predictive value for choledocholithiasis, the combination of normal bilirubin, normal alkaline phosphatase, and normal transaminases makes biliary obstruction extremely unlikely. 2

Primary Diagnosis Is Pneumonia, Not Biliary Disease

• The patient was admitted with bilateral pneumonia and is being appropriately treated with ceftriaxone and doxycycline. 1 His fever (101.2°F), oxygen requirement (2L NC), and leukocytosis (WBC 11.6) are consistent with his pulmonary infection.

• Right upper quadrant pain can be referred pain from right lower lobe pneumonia or pleurisy, which is a common pitfall when evaluating RUQ pain in patients with concurrent pulmonary pathology. 3

ERCP Carries Significant Risk Without Clear Benefit

• ERCP is a therapeutic intervention with substantial complication rates: pancreatitis 3–5%, bleeding 2% (with sphincterotomy), cholangitis 1%, and mortality 0.4%. 1 These risks are unacceptable when there is no confirmed biliary obstruction requiring intervention.

• ERCP should only be performed after non-invasive imaging (ultrasound ± MRCP) has confirmed biliary obstruction requiring intervention. 1

Recommended Diagnostic Algorithm

Step 1: Continue Current Management for Pneumonia

• Complete the antibiotic course for bilateral pneumonia with ceftriaxone and doxycycline. 1 Monitor for clinical improvement in fever, oxygen requirement, and leukocytosis.

• Reassess RUQ pain after treating the pneumonia, as referred pain from pulmonary pathology often resolves with treatment of the underlying infection. 3

Step 2: Consider Ceftriaxone-Induced Biliary Pseudolithiasis

• Ceftriaxone can cause biliary sludge, pseudolithiasis, and even hyperbilirubinemia in adults, though this patient's bilirubin remains normal. 4, 5 The ultrasound finding of "choledocholithiasis cannot be excluded" may reflect ceftriaxone-related biliary precipitation rather than true stones.

• If RUQ pain persists after completing ceftriaxone therapy, consider switching to an alternative antibiotic (e.g., levofloxacin or another respiratory fluoroquinolone) to eliminate drug-induced biliary effects. 4, 5

Step 3: Obtain MRCP Only If Clinical Suspicion Persists

• If RUQ pain persists after treating pneumonia and discontinuing ceftriaxone, order MRCP (without IV contrast) as the next diagnostic step. 1 MRCP achieves 85–100% sensitivity and 90% specificity for detecting choledocholithiasis and provides comprehensive biliary tree evaluation. 1

• MRCP is superior to repeat ultrasound or CT for detecting bile duct stones, particularly in the distal common bile duct where ultrasound has limited sensitivity (22.5–75%). 1

• Do not proceed directly to ERCP without MRCP confirmation of stones requiring intervention, as this exposes the patient to unnecessary procedural risk. 1

When ERCP Would Be Indicated

Urgent ERCP (Within 24 Hours)

• Acute cholangitis (Charcot's triad: fever, jaundice, RUQ pain) with elevated bilirubin and alkaline phosphatase. 1 This patient has fever and RUQ pain but lacks jaundice and cholestatic liver enzymes.

Early ERCP (Within 72 Hours)

• MRCP-confirmed common bile duct stone with persistently dilated CBD and rising bilirubin or alkaline phosphatase. 1

• Biliary pancreatitis (lipase >3× upper limit of normal) with imaging-confirmed choledocholithiasis. 1 This patient's lipase is normal (26 U/L).

Critical Clinical Pitfalls to Avoid

• Do not perform ERCP based solely on ultrasound stating "choledocholithiasis cannot be excluded." 1 This equivocal language reflects the inherent limitation of ultrasound for visualizing the distal CBD, not a positive finding requiring intervention.

• Do not ignore the primary diagnosis of pneumonia when evaluating RUQ pain. 3 Pulmonary pathology commonly causes referred abdominal pain, and treating the underlying infection often resolves the abdominal symptoms.

• Do not overlook ceftriaxone as a cause of biliary findings on imaging. 4, 5 Drug-induced biliary pseudolithiasis is reversible upon discontinuation and does not require endoscopic intervention.

• Remember that a normal CBD caliber on ultrasound has a 95–96% negative predictive value for choledocholithiasis. 1 While this patient's CBD is minimally dilated, the absence of cholestatic liver enzymes makes clinically significant obstruction extremely unlikely.